Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer

Nature

Volumn 448, Issue 7153, 2007, Pages 561-566

  Soda, Manabu ^a   Choi, Young Lim ^a   Enomoto, Munehiro ^a   Takada, Shuji ^a   Yamashita, Yoshihiro ^a   Ishikawa, Shunpei ^b   Fujiwara, Shin Ichiro ^a   Watanabe, Hideki ^a   Kurashina, Kentaro ^a   Hatanaka, Hisashi ^a   Bando, Masashi ^a   Ohno, Shoji ^a   Ishikawa, Yuichi ^c   Aburatani, Hiroyuki ^b,d   Niki, Toshiro ^a   Sohara, Yasunori ^a   Sugiyama, Yukihiko ^a   Mano, Hiroyuki ^a,d  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c CANCER INSTITUTE   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; ECHINODERM MICROTUBULE ASSOCIATED PROTEIN LIKE 4; EPIDERMAL GROWTH FACTOR RECEPTOR; MICROTUBULE ASSOCIATED PROTEIN 4; MOLECULAR MARKER; UNCLASSIFIED DRUG;

CANCER; ECHINODERM; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC MARKER; MUTATION; PROTEIN; RODENT; TUMOR;

ADULT; AMINO ACID SEQUENCE; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL STRAIN 3T3; CHROMOSOME 2P; CONTROLLED STUDY; ECHINODERM; FIBROBLAST; GENE FUSION; GENE IDENTIFICATION; GENE MUTATION; GENETIC TRANSCRIPTION; GENETIC TRANSFORMATION; HUMAN; LUNG NON SMALL CELL CANCER; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE PROTEINS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMES, HUMAN, PAIR 2; HUMANS; INVERSION, CHROMOSOME; LUNG NEOPLASMS; MICE; MICROTUBULE-ASSOCIATED PROTEINS; MOLECULAR SEQUENCE DATA; MUTATION; ONCOGENE PROTEINS, FUSION; PROTEIN-TYROSINE KINASES; SERINE ENDOPEPTIDASES;

ECHINODERMATA; MUS MUSCULUS;

EID: 34547638047     PISSN: 00280836     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/nature05945     Document Type: Article

References (27)

1. Jemal, A. et al. Cancer statistics, 2006. CA Cancer J. Clin. 56, 106-130 (2006).
2. Schiller, J. H. et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N. Engl. J. Med. 346, 92-98 (2002).
3. Lynch, T. J. et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N. Engl. J. Med. 350, 2129-2139 (2004).
4. Paez, J. G. et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304, 1497-1500 (2004).
5. Druker, B. J. et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N. Engl. J. Med. 344, 1031-1037 (2001).
6. Pao, W. et al. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc. Natl Acad. Sci. USA 101, 13306-13311 (2004).
7. Yoshizuka, N. et al. An alternative transcript derived from the Trio locus encodes a guanosine nucleotide exchange factor with mouse cell-transforming potential. J. Biol. Chem. 279, 43998-44004 (2004).
8. Hatanaka, H. et al. Transforming activity of purinergic receptor P2Y, G-protein coupled, 2 revealed by retroviral expression screening. Biochem. Biophys. Res. Commun. 356, 723-726 (2007).
9. Choi, Y. L. et al. Identification of a constitutively active mutant of JAK3 by retroviral expression screening. Leuk. Res. 31, 203-209 (2007).
10. Fujiwara, S. et al. Transforming activity of the lymphotoxin-β receptor revealed by expression screening. Biochem. Biophys. Res. Commun. 338, 1256-1262 (2005).
11. Pollmann, M. et al. Human EML4, a novel member of the EMAP family, is essential for microtubule formation. Exp. Cell Res. 312, 3241-3251 (2006).
12. Eichenmuller, B., Everley, P., Palange, J., Lepley, D. & Suprenant, K. A. The human EMAP-like protein-70 (ELP70) is a microtubule destabilizer that localizes to the mitotic apparatus. J. Biol. Chem. 277, 1301-1309 (2002).
13. Smith, T. F., Gaitatzes, C., Saxena, K. & Neer, E. J. The WD repeat: a common architecture for diverse functions. Trends Biochem. Sci. 24, 181-185 (1999).
14. Morris, S. W. et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263, 1281-1284 (1994).
15. Shiota, M. et al. Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3. Oncogene 9, 1567-1574 (1994).
16. Pulford, K., Morris, S. W. & Turturro, F. Anaplastic lymphoma kinase proteins in growth control and cancer. J. Cell. Physiol. 199, 330-358 (2004).
17. Galkin, A. V. et al. Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK. Proc. Natl Acad. Sci. USA 104, 270-275 (2007).
18. Donella-Deana, A. et al. Unique substrate specificity of anaplastic lymphoma kinase (ALK): development of phosphoacceptor peptides for the assay of ALK activity. Biochemistry 44, 8533-8542 (2005).
19. XL chimeric gene with transforming activity. Am. J. Pathol. 160, 1487-1494 (2002).
20. Palacious, R. & Steinmetz, M. IL-3 dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo. Cell 41, 727-734 (1985).
21. Kaul, K. L. Molecular detection of Mycobacterium tuberculosis: impact on patient care. Clin. Chem. 47, 1553-1558 (2001).
22. Marzec, M. et al. Inhibition of ALK enzymatic activity in T-cell lymphoma cells induces apoptosis and suppresses proliferation and STAT3 phosphorylation independently of Jak3. Lab. Invest. 85, 1544-1554 (2005).
23. Li, R. et al. Design and synthesis of 5-aryl-pyridone-carboxamides as inhibitors of anaplastic lymphoma kinase. J. Med. Chem. 49, 1006-1015 (2006).
24. Watanabe, S., Itoh, T. & Arai, K. JAK2 is essential for activation of c-fos and c-myc promoters and cell proliferation through the human granulocyte-macrophage colony-stimulating factor receptor in BA/F3 cells. J. Biol. Chem. 271, 12681-12686 (1996).
25. Duyster, J., Bai, R. Y. & Morris, S. W. Translocations involving anaplastic lymphoma kinase (ALK). Oncogene 20, 5623-5637 (2001).
26. Onishi, M. et al. Applications of retrovirus-mediated expression cloning. Exp. Hematol. 24, 324-329 (1996).
27. Yamashita, Y. et al. Sak serine/threonine kinase acts as an effector of Tec tyrosine kinase. J. Biol. Chem. 276, 39012-39020 (2001).